HemaSphere (Aug 2023)

PB1900: COMBINED TREATMENT WITH VENETOCLAX PLUS HYPOMETHYLATING AGENT OR CYTARABINE VERSUS TREATMENT WITH HYPOMETHYLATING AGENT ALONE IN ACUTE MYELOID LEUKEMIA IN POOR PROGNOSIS PATIENTS.

  • Minerva Montalvo Saavedra,
  • Alvaro Bienert Garcia,
  • Belén Pérez-Pinilla,
  • Paula Reyes González-Casanova,
  • Marta Díaz-Lopez,
  • Jose Gregorio Torres Quiroz,
  • Alberto Martinez Llorens,
  • Cielo de Los Ángeles Lorena Borja Goyeneche,
  • Carolina Lacalzada Higueras,
  • Bernardo Javier González González,
  • Miguel Teodoro Hernandez Garcia,
  • Sunil Lakhwani Lakhwani

DOI
https://doi.org/10.1097/01.HS9.0000974424.53907.97
Journal volume & issue
Vol. 7
p. e5390797

Abstract

Read online

No abstracts available.